Latest stories on MIRA
MIRA-55 toxicology results advance non-opioid pain program
TipRanks67 · bullishproduct/pr
Mira Pharmaceuticals announces results from MIRA-55 studies
The Fly55 · neutralproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND
Business Insider63 · neutralproduct/pr
MIRA Reports Positive Preclinical Results for Obesity Candidate SKNY-1
TipRanks63 · neutralproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
StockTitan63 · neutralproduct/pr
MIRA Pharmaceuticals Receives Nasdaq Minimum Bid Price Notice
TipRanks38 · neutralgeneral
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K28 · bearishgeneral
MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies
StockTitan63 · neutralproduct/pr
MIRA Pharmaceuticals announces positive preclinical results for MIRA-55
TipRanks63 · neutralproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Reports Positive Preclinical Data for SKNY-1 Program
TipRanks63 · neutralproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Advances Ketamir-2 Into FDA-Accepted Phase 2a Trial
TipRanks67 · bullishproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Pharmaceuticals Appoints New Fractional Chief Financial Officer
TipRanks55 · neutralgeneral
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Pharmaceuticals Secures Unified Global Rights to Pipeline
TipRanks63 · neutralproduct/pr
MIRA Pharmaceuticals Secures Worldwide Exclusive Rights to MIRA-55 and SKNY-1 | MIRA Stock News
StockTitan67 · bullishproduct/pr